Member Info for Celtic007

Https://www.google.com/amp/s/news.sky.com/story/amp/asos-offloads-topshop-stake-amid-battle-with-asian-rivals-13210033

PP1..TALKING detritus again FFS ...

roberto, look how stupid you look ffs. any one with any respect now sees you for the bawbag that you are.

all brokers have different views and that is fine. you , just post total *******s ffs.

Yep I do. He said that our molecule chk1 could prove to be more money making .

Yep Roberto , you sound like a desperate fool. Literally begging people. Not going to happen. Asos has strong financial holders behind it

i do opposite to these *******s. th

Roberto , you still cannot keep your mouth shut today. You are a guy in shock today and have a cheek telling other people that they are misleading others.

You and your other half pp1 are nasty scum

This is still a very tasty TO target and undervalued. Think there was a article recently stating the ridiculous low values of companies on the market and asos was one of them.

PP1 BE IN THE TOILET

Why the f are you asking us these questions? Thought you knew all the answers. Twat

Thanks hot. That CHK has to go into market, no it's or buts . .amazing combo drug

.

You must be panicking, boy...you can sense it fool

Where are you scum

The only positive bmo momentum i want to see is you going off a cliff, attached to Roberto FFS

The most step in sareum history is the next one. This data package is so important as it will determine how much indications can we target . If these indications are high, brilliant. Then the pharmaceutical will want to know it's mechanism same to other tyk2 in market or different, if similar then brilliant as shows validation that it will work on these already licensed if medications, like psoriasis. If mechanism unknown, a bit special, will come down to safety profile shown in trial.

The data package needs to sing. If it does then the pharmaceuticals have to decide , move now for both or wait and pay bigger fee later or worse let it be taken by a competitor .

Here PP1. are you shorting this? If yes, then biased. If no, then why here FFS

Simples...a twask.

All about risk reward.....potnak. remember the pharmauceuticals looking at the data package will know how it works and how other previous licenced drugs in same class work.

If more than one interested, well then you have to be ready to lose, if play safe.

Thanks potnak. Yep, comes to the biomarkers package

Roberto , you are here daily like a bloody antibiotic resistant bacteria. You and PP1, TWO FOOLS.

Asos will come through this, I trust the people at the top.

Now shut the f up.

Hi potnak. Thanks. At this stage , if good biomarker data , could we achieve £3.50 a share TO? .

I can.